Medicare starts a long road to cutting prices for drugs, starting with 10 costing it $50.5 billion annually a health policy analyst explains why negotiations are promising but will take years
Webpage
Overview
Research
Other
View All
Overview
author list (cited authors)
complete list of authors
publication date
publisher
Research
keywords
Aging
Biden Administration
Drug Prices
Drug Pricing
Gerontology
Inflation Reduction Act Of 2023
Medicare
Other
URL
https://theconversation.com/medicare-starts-a-long-road-to-cutting-prices-for-drugs-starting-with-10-costing-it-50-5-billion-annually-a-health-policy-analyst-explains-why-negotiations-are-promising-but-will-take-years-212503
key
https://theconversation.com/medicare-starts-a-long-road-to-cutting-prices-for-drugs-starting-with-10-costing-it-50-5-billion-annually-a-health-policy-analyst-explains-why-negotiations-are-promising-but-will-take-years-212503
note
An article submitted to The Conversation